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AbstrACt
Introduction Examining patient and public understanding 
of overtesting and overdiagnosis (OverTD) is vital for 
reducing the burden of OverTD. Studies from disparate 
contexts, disciplines and focusing on disparate healthcare 
issues have examined patient and public understanding 
of OverTD. A synthesis is needed to bring this literature 
together, examine common themes, strengthen 
conclusions and identify gaps. This will help steer further 
research, policy and practice to improve patient and public 
understanding of OverTD. The objective of this study is 
to synthesise qualitative research data about patient and 
public understanding of OverTD.
Methods and analysis A thematic meta- synthesis 
will be used to synthesise primary qualitative research 
and qualitative components of primary mixed- methods 
research about patient and public understanding of 
OverTD. Studies published in English will be included. 
These will be identified using systematic searches from 
inception to March 2020 in the Scopus, CINAHL, PsycINFO 
and MEDLINE databases. Studies that satisfy eligibility 
criteria will be assessed for methodological quality using 
the Critical Appraisal Skills Programme (CASP) checklist. 
Thematic meta- synthesis will comprise three stages: (1) 
line- by- line coding; (2) generation of descriptive themes 
and (3) generation of analytic themes. Confidence in the 
synthesis findings will be assessed using the Grading 
of Recommendations Assessment, Development and 
Evaluation Confidence in Evidence (GRADE CERQual) 
approach. A summary of GRADE CERQual results will 
be presented alongside the key themes. Study eligibility 
screening, data extraction, analysis and the CASP 
and GRADE CERQual assessments will be undertaken 
independently by two review authors.
Ethics and dissemination Ethics approval is not required 
for this secondary analysis of published data. The results 
will be disseminated in peer- reviewed journals and may be 
presented in conference papers and elsewhere.
PrOsPErO registration number CRD42020156838
IntrOduCtIOn
The high prevalence of overtesting, overdi-
agnosis and overtreatment across a range 
of health conditions is a global challenge.1 
Overtesting is when diagnostic tests that are 
not indicated are used.2 It can lead to overdi-
agnosis,3 which is when a diagnosis is made 
according to professional standards, but 
when it is unlikely to benefit the patient.4 
Overtesting and overdiagnosis (OverTD) can 
lead to overtreatment,2 5 which is treatment 
that does more harm than good.6
It is important to reduce overtesting, overdi-
agnosis and overtreatment.7 8 Overtesting can 
lead to harms including unnecessary inva-
sive procedures, false positives and misdiag-
noses.2 Overdiagnosis can lead to unwanted 
behavioural and psychological responses 
in patients, such as reduced participation 
in usual activities,9 stress and anxiety.10 11 A 
diagnosis primes patients and physicians to 
commence treatment, even for benign condi-
tions.6 Overtreatment can lead to patient 
suffering, treatment- related complications, 
loss of quality of life, lost productivity and 
other burdens.6 12 Medical overuse is massively 
costly to healthcare systems and to patients 
and their families,2 13 14 and must be reduced 
to maintain healthcare system sustainability.15
Improving patient and public under-
standing of OverTD is key to reducing 
their incidence as well as the incidence of 
strengths and limitations of this study
 ► The first meta- synthesis of qualitative research 
about patient and public understanding of overtest-
ing and overdiagnosis.
 ► Systematic search strategy informed by up- to- date 
evidence about database and keyword optimisation.
 ► Confidence in the qualitative meta- synthesis 
findings strengthened by use of the Grading of 
Recommendations Assessment, Development and 
Evaluation Confidence in Evidence approach.
 ► Scope of the research limited by the exclusion of 
studies not written in the English language and of 
grey literature.
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overtreatment.15 16 Both patients and the public need to be 
aware of OverTD, as people regularly transition between 
being in and out of medical care,17 and their medical 
decision making is informed by beliefs that are formed 
and reformed across contexts.18 Presently, patients and 
the public often drive medical overuse. Some patients 
and members of the public tend to over- rely on tests 
and diagnoses,19 overestimating their benefits,20 21under-
estimating their risks22 as they cope with uncertainty 
poorly.3 23 Few are aware that overtesting or overdiagnosis 
occurs,24 25 and those who are often find the phenomena 
difficult to understand.25 26 Research suggests that patient 
outcomes would be improved if they understood OverTD 
better.27 28 Patients with better knowledge about OverTD 
make more appropriate screening and treatment deci-
sions.25 Patient knowledge also influences the tests and 
treatments prescribed by the medical practitioners,29 who 
in some cases overuse medical interventions.30 31 Patients 
and the public want to be informed about OverTD,21 and 
need to understand both risks and benefits of medical 
interventions in order to participate in shared decision 
making.32
Research is increasingly examining patient and public 
understanding of OverTD.33 Patient and public under-
standings of OverTD have been surveyed,24 34 and qual-
itatively examined, in relation to a range of conditions 
and in multiple contexts.21 26–28 35 Researchers have 
studied the challenges of communicating about OverTD 
to the general public27 36 37 as well as to particular patient 
groups, such as patients with low health literacy.38 Strat-
egies are being developed to overcome these commu-
nication challenges. They include the development of 
decision aids, which inform patients about the risks as 
well as benefits of particular medical interventions,25 such 
as breast cancer screening,39 and assist them in making 
evidence- backed healthcare decisions.40 Other research 
has focused on refining patient educational tools. This 
includes studying how different concepts of OverTD reso-
nate with patients and the public,41 the effects of informa-
tion about overdiagnosis on patient screening decisions,21 
and studying patients’ understandings of their own diag-
noses.10 The use of mass media to reduce OverTD has 
also been studied, such as how media narratives can influ-
ence cancer screening decisions42 43 or promote better 
management of back pain.44
Despite progress in research, important gaps in 
knowledge remain.16 45 46 First, existing studies are scat-
tered across disciplines, contexts and focus on disparate 
medical conditions.47 It is difficult to appraise the overall 
state of research or glean its collective insights. Second, 
while it is known that patients and the public find OverTD 
unintuitive, little is known about why.15 48 A meta- synthesis 
of qualitative data from research examining patient and 
public understanding of OverTD will help address these 
gaps. It will systematise insights from disparate disciplines, 
contexts and topic areas by identifying descriptive themes 
in the body of literature. The synthesis will also identify 
analytic themes about the reasons for poor public and 
patient understanding of OverTD. These findings will 
inform future research by highlighting priority areas for 
further enquiry. An increased understanding about why 
patients and the public struggle to understand OverTD 
may inform the development of educational interven-
tions and other practice to improve their understanding.
ObjECtIvE
The objective of this study is to synthesise data from qual-
itative research on patient and public understanding of 
OverTD.
MEthOds
Thematic meta- synthesis will be used to examine primary 
qualitative research and qualitative components of 
mixed- methods research about patient and public under-
standing of OverTD.
The protocol is presented in accordance with the 
Preferred Reporting Items for Systematic review and 
Meta- Analysis Protocols (PRISMA- P) checklist49 (avail-
able in online supplementary appendix 1).
study selection criteria
Study selection criteria and their rationale are described 
in table 1.
search methods
The search process will comprise first an informal scoping 
stage to develop search strategies, and then a formal main 
stage to identify and collate eligible studies. The main 
stage will identify English language studies indexed in 
four databases from inception until March 2020.
The scoping stage will be exploratory. Its aims are to 
become familiar with the literature, refine search param-
eters, identify MeSH terms and keywords and test the 
preliminary search strategy.
The main stage will comprise the formal literature 
search. It will be informed by the scoping stage, by search 
strategy guidelines from the Cochrane Collaboration,50 51 
guidelines for optimising database searches for medical 
qualitative research52 and guidelines for searching the 
individual databases used, such as for MEDLINE53 and 
PsycINFO.54 Search filters will be identified for each of 
the inclusion criteria. A subject librarian will contribute 
to the development of the search strategy.
The following databases will be used: Scopus, CINAHL, 
MEDLINE and PsycINFO. These were chosen because 
they are most likely to index studies about patient 
and public understanding of OverTD: social research 
(Scopus); medicine/public health/health communi-
cation research (MEDLINE, CINAHL); psychological 
research (PsycINFO) and generalist fields (Scopus). Data-
base selection was also informed by research showing that 
Scopus, MEDLINE and CINAHL searches retrieve some 
of the largest numbers of qualitative health studies, and 
the largest number of qualitative health studies not listed 
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Table 1 Study selection criteria
Inclusion criterion Rationale
Primary, published, peer- reviewed 
studies
Restricting the synthesis to primary, published, peer- reviewed studies matches the aims of 
examining primary evidence.
Studies examining understanding Understanding is defined as objectual understanding: understanding of something, such as 
collection of ideas or a subject matter71. Studies examining participants’ knowledge, perceptions, 
sentiments, values or experiential understanding will be included. This reflects that understanding 
can be developed through experiential learning72, emotional learning73 as well as abstract learning.
Among patients and/or the public The synthesis will examine understanding among both patients and the public. People regularly 
transition between being one or the other17, and make diagnostic and screening decisions drawing 
on understanding they developed overtime and in either role. So, it is appropriate to examine 
understanding of OverTD among both groups.
It will be distinguished whether studies are about patients, the public or both. People have a differing 
engagement with health decision making when they are patients or the public74. To account for 
this, synthesis results for each group will be compared, and important intergroup differences will be 
considered in study outcomes.
Of overtesting and/or overdiagnosis 
(OverTD)
Studies about both overtesting (OT) and overdiagnosis (OD) will be included, as both are deeply 
interlinked and underpinned by common broader patient ideas about healthcare. However, 
understandings of OT and OD may differ. To account for this, studies will be classified based 
on whether they examine OT, OD or both. The synthesis results will be compared by these 
classifications, and important differences will be accounted for.
Synonymous concepts to overtesting and overdiagnosis will be included, such as ‘over- detection’ 
and ‘overuse of diagnostic testing’. The term ‘overdiagnosis’ was popularised relatively recently75, 
but it was predated by earlier terms76, and it is important to capture these earlier studies.
Studies which did not explicitly aim to understand how to inform patients or the public about 
OverTD are outside the scope of this synthesis and will be excluded. Studies that only address 
overtreatment and not overtesting or overdiagnosis will also be excluded.
Either qualitative or mixed- methods 
study design
Mixed- methods studies will be included where their qualitative components can still be examined in 
the thematic meta- synthesis.
Quantitative components of mixed- methods studies will be excluded, as will studies where it is not 
possible to differentiate between quantitative and qualitative components of analysis.
Published in the English language Only English language studies will be included, as the authors are English speakers, and relying on 
translations of non- English studies could introduce inaccuracies into the analysis.
Published in any year There will be no date restrictions: older insights may still be relevant.
Conducted in any setting There will be no setting restrictions: studies from all settings may potentially contain transferable 
insights about patient and public understandings of OverTD.
Focusing on the general concepts 
of OverTD and/or in relation to any 
condition/s or interventions
While patient and public understanding of OverTD may differ depending on medical conditions, 
there may be underlying themes across conditions, so it is relevant to include studies relating to any 
conditions. The condition/s which a study focuses on will be noted. Study themes will be compared 
by conditions in analysis if the sample characteristics make this viable.
by other databases.52Additionally, PsycINFO was included 
despite indexing relatively few unique studies,52 because 
it may index studies about psychosocial factors related to 
understanding OverTD. Examples of all search strategies, 
including filters for each criterion and Boolean opera-
tors, are included in online supplementary appendix 2.
Even where database selection is optimised, one study 
shows that 7% of qualitative health studies that fit the 
search parameters will not be retrieved, with the majority 
not indexed by major databases.52 To increase the chances 
of relevant studies being retrieved, the reference lists of 
all studies included in the final sample will be scanned 
for eligibility, and experts in the field will be contacted 
to identify studies that may have been missed. Poten-
tially eligible studies will be added to the data screening 
process (described below).
The search may be rerun and results updated at a 
future date if required (ie, after 12 months if study is not 
yet published).
selection of studies
Study selection will comprise the following steps:
1. All study records identified using the search strategy 
will be extracted with a PDF of the study manuscript 
into EndNote reference management software.
2. Duplicate studies will be removed from the data.
3. Study titles and abstracts will be screened for eligibility 
by two authors (TR and RH) working independently. 
Eligible studies and studies where eligibility cannot be 
clearly determined from the abstract and title will be 
included for full- text review.
4. Full texts will be independently read and examined 
for eligibility by TR and RH using a standardised 
form. Ineligible studies will be screened out, and the 
reason for exclusion recorded. Eligible studies will 
be included in the analysis. Where the two authors 
cannot agree on eligibility after discussion, a third au-
thor (DAO) will judge whether the study should be 
included.
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5. The final sample of full text studies will be extracted to 
NVivo research software.
The screening process will be reported in a PRISMA 
diagram.55
data extraction
The complete study manuscript will be extracted into 
NVivo. Analysis will be undertaken on the Results sections 
of manuscripts, including themes, subthemes and primary 
data as reported in the manuscripts, such as participant 
quotes. Primary data included in tables and sections of 
manuscripts may also be analysed.
For each study, a standardised data collection form will 
be completed to capture:
 ► Study details: authors, year of publication, journal in 
which study was published.
 ► Research question/s.
 ► Participants: sample size, demographic character-
istics, whether they are patients and/or the public, 
methods of participant recruitment and selection.
 ► Setting: type/s of healthcare and/or conditions the 
study focused on, whether the study examined over-
testing and/or overdiagnosis, country where study 
was completed, whether study was in urban or rural 
settings.
 ► Method of data collection (such as interview or 
survey).
 ► Method of data analysis (such as narrative analysis or 
discourse analysis).
These details will be added as classifying information to 
the extracted full text studies in NVivo.
Assessment of quality of included studies
The Critical Appraisal Skills Programme (CASP) qual-
itative checklist56 will be used to systematically examine 
the reliability, validity and usefulness of individual studies 
in the synthesis. The 10- item checklist comprises nine 
fixed- response questions that can be answered: yes/can’t 
tell/no (‘yes’ indicates a positive score), and one text- 
response question. Two authors (TR and RH) will inde-
pendently complete the CASP checklist for each study, 
and any disagreements in scoring will be resolved by a 
third author (DAO). A summary of CASP checklist results 
will be reported as a table and interpreted in text.
synthesis and analysis
A thematic meta- synthesis of the Results sections of manu-
scripts will be undertaken. Analysis will comprise three 
main stages57: first, line- by- line coding; next, descriptive 
thematic development, and finally; analytical theme 
development.
The thematic meta- synthesis method was chosen for 
several reasons. It fits the gaps this research responds to: 
the descriptive phase will address the need to systematise 
insights from disparate disciplines, contexts and topic 
areas, while the analytical phase is an interpretive tool 
with which synthesised studies can be re- examined to 
study why patients and the public find OverTD so difficult 
to understand. Furthermore, thematic analysis is suit-
able for handling data from disparate contexts,58 which 
fits this synthesis where included studies are likely to be 
heterogeneous. Finally, thematic meta- synthesis is partic-
ularly suited to informing policy and practice,59 which 
is an important consideration for this research. The 
synthesis assumes an objective idealist epistemic position. 
The synthesised studies are considered to convey some-
thing about reality, but this reality is conveyed through a 
subjective lens.60 This is also assumed for the findings of 
this synthesis.
The first stage of analysis will be line- by- line coding. 
Authors will familiarise themselves with the data. TR will 
inductively generate initial codes for ideas in the data, 
coding over several iterations until no new codes are 
needed to capture ideas. Single data fragments can be 
assigned multiple codes. Once TR is satisfied with the code 
frame, he will code the whole dataset, checking coding 
for data coverage and refining it as necessary. A second 
author (RH) will check a randomly selected sample of 
10% of coded data for coding accuracy. A disagreement 
score will be calculated, and disagreements discussed 
and resolved, drawing on the wider team if required. An 
agreement score of 85% or higher will be targeted.61 If 
the agreement score is low, reasons for this will be inves-
tigated, and line- by- line coding may need to be repeated.
The second stage of analysis will be the development of 
descriptive themes to organise existing ideas in the data. 
TR and RH will independently organise individual codes 
into broader themes. The two authors will then coop-
erate to develop one set of common descriptive themes, 
discussing them with the wider author group. Themes 
will be checked for data coverage and internal homo-
geneity.62 External heterogeneity will not be assessed, as 
this is problematic where individual data can be multi-
coded. Themes will be revised until their fit with data is 
optimised.
The third stage of analysis will be the development of 
analytical themes capturing the barriers and enablers 
to patient and public understanding of OverTD. This 
stage will be interpretative and will seek to generate new 
ideas.57 63 TR and RH will independently re- examine the 
data organised into descriptive themes to infer what the 
barriers and enablers to understanding OverTD are.64 
This phase will rely on the authors’ subjectivities, and 
the authors will take a reflexive approach to minimise 
problems in interpretation and improve transparency 
in analysis.65 TR and RH will meet to compare their 
analytical themes. As part of researcher reflexivity, they 
will discuss the factors that led to their interpretations, 
including their assumptions, logical inferences and how 
their interpretations may have been shaped by the prede-
termined research aims. Researcher reflexivity will also be 
addressed in peer- reviewed publications resulting from 
this research, including consideration about the ways in 
which the authors’ own positions could have influenced 
the study design, analysis and the interpretation of find-
ings. TR and RH will determine the analytical themes, 
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which will be discussed and finalised with the wider 
author group.
Descriptive and analytical thematic results will be 
compared across a range of classifying variables, such 
as whether data are from studies about patients/the 
public/both, and whether data are from studies inves-
tigating understanding of overtesting/overdiagnosis/
both. Notable comparative differences will be reported 
in the Results. Descriptive and analytical themes will be 
tabulated and paired with exemplary data fragments. A 
separate table will display how the data from each study is 
represented in the coding.
Assessment of confidence in findings
The Grading of Recommendations Assessment, Devel-
opment and Evaluation- Confidence in Evidence from 
Reviews of Qualitative research (GRADE- CERQual) 
approach66 will be used to assess confidence in the 
analytic synthesis results. GRADE- CERQual is used to 
consider four factors about studies contributing to 
review findings: (1) methodological limitations; (2) rele-
vance; (3) adequacy of supporting data and (4) coher-
ence. The overall confidence in each review finding 
(ie, for each theme generated) will be graded as: high, 
moderate, low or very low. GRADE- CERQual assess-
ments will be undertaken independently by two authors 
(TR and RH). Any disagreements will be discussed until 
consensus is achieved. Review findings, the confidence 
judgement for each finding and an explanation of the 
judgement will be presented in a Summary of Qualita-
tive Findings table.
Assessment of methodological limitations
Methodological limitations in the synthesis will be judged 
based on the aggregated CASP checklist results for all 
included studies (described earlier).
Assessment of relevance
Relevance is ‘the extent to which the body of data from 
the primary studies supporting a review finding is appli-
cable to the context specified in the review question’ 
(Noyes et al, p53).67 Across synthesised studies contrib-
uting to each review finding, we will consider the years 
of publication, settings in which studies were conducted, 
target audiences and specificity of the findings. These will 
determine how relevant the body of synthesised studies 
is for developing knowledge about contemporary patient 
and public understanding of OverTD in general.
Assessment of adequacy
Adequacy is the quantity and richness of data contributing 
to a review finding.68 Quantity is defined as the number of 
studies or data fragments supporting a theme. Richness is 
defined as the extent to which themes are supported by 
detailed, qualitative descriptions. Both parameters will be 
considered to judge the adequacy of data for supporting 
each theme in the synthesis results.
Assessment of coherence
Coherence is ‘how clear and cogent the fit is between the 
data from the primary studies and a review finding that 
synthesises that data’ (Colvin et al, p35).69 To examine 
coherence, the synthesis themes will be compared against 
the results of individual synthesised studies, examining 
the extent to which the synthesis findings align with indi-
vidual study findings.
Patient and public involvement
A health consumer advocate from the Consumer’s Health 
Forum of Australia was consulted in the development of 
this protocol. They will advise on the interpretation of the 
synthesis results.
rEsults
The Results will comprise two subsections:
1. The sample profile, describing classifying information 
about the synthesised studies.
2. The thematic meta- synthesis results. Both descriptive 
and analytical themes will be reported. The descrip-
tive themes will form a minor part of the Results, sum-
marised in a table and briefly interpreted in text. The 
analytical themes will form a main part of the Results, 
with all major analytical themes tabulated, described 
in text and paired with exemplary data fragments and 
GRADE- CERQual assessment findings.
The meta- synthesis will be reported in accordance with 
the enhancing transparency in reporting the synthesis of 
qualitative research statement.70
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